US EditionXtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft – Ortho Spine News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Xtant launches next-gen nanOss Strata synthetic bone graft - BioTuesdays
Xtant Medical (NYSE American: XTNT) has announced the commercial launch of its next-generation innovative synthetic bone graft in the nanOss line, Strata. According to Xtant, the nanocrystalline structure of hydroxycarbonapatite, used in the nanOss Strata, is designed to closely mimic human bone and increase the surface area for improved osteoconductivity and stimulation of the patient’s cellular activity on the surface of the graft after implan…
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft – Ortho Spine News
nanOss Strata is designed to more closely mimic the structure of human bone, increase the graft’s surface area, improve osteoconductivity and enhance the stimulation of cellular activity BELGRADE, Mont., Dec. 11, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced the commercial launch of its next-generation i
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
